longkankerpatient.be évaluation et analyse
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Leuven Lung Cancer Group | |
| Description | LeuvenLungCancerGroup.be Deze website maakt gebruik van Cookies. Bij het verder gebruik van de website gaat u akkoord met de cookie voorwaarden. ( meer info ) Leuven LungCancer Gr |
| Keywords | , |
Server Information
| WebSite | |
| Host IP | 83.217.74.136 |
| Location | Belgium |
Plus à explorer
longkankerpatient.be Évaluation
|
Euro€813,917
Dernière mise à jour: 2022-10-04 04:24:43
longkankerpatient.be a un classement mondial Semrush de 13,004,158. longkankerpatient.be a une valeur estimée à € 813,917, sur la base de ses revenus publicitaires estimés. longkankerpatient.be reçoit environ 93,914 visiteurs uniques chaque jour. Son serveur Web est situé au Belgium, avec l'adresse IP 83.217.74.136.Selon SiteAdvisor, longkankerpatient.be est sûr à visiter. |
Trafic & Estimations de la valeur
| Valeur d'achat/vente | Euro€813,917 |
| Revenus publicitaires quotidiens | Euro€752 |
| Revenus publicitaires mensuels | Euro€22,540 |
| Revenus publicitaires annuels | Euro€270,471 |
| Visiteurs uniques quotidiens | 6,261 |
| Remarque: Toutes les valeurs de trafic et de revenus sont des estimations. | |
DNS Records
| Host | Type | TTL | Data |
| longkankerpatient.be. | A | 3599 | IP: 83.217.74.136 |
| longkankerpatient.be. | AAAA | 3599 | IPV6: 2a00:1c98:1000:10a4:0:1:3921:af28 |
| longkankerpatient.be. | NS | 3600 | NS Record: ns3.combell.net. |
| longkankerpatient.be. | NS | 3600 | NS Record: ns4.combell.net. |
HtmlToTextCheckTime:2022-10-04 04:24:43
| Deze website maakt gebruik van Cookies. Bij het verder gebruik van de website gaat u akkoord met de cookie voorwaarden. ( meer info ) Leuven LungCancer Group.be Welkom op de website van de Leuven Lung Cancer Group Welcome to the website of the Leuven Lung Cancer Group May 2022 Selected Trial: Artemide: A study to assess safety and efficacy of AZD2936 (a combined anti-PD1/anti-TIGIT) in advanced/metastatic NSCLC in pretreated patients May 2022 Selected Trial: Mariposa-2 : Phase 3 study of Amivantamab/Lazertinib plus platinum-based chemotherapy versus platinum-based chemotherapy in EGFR-mutated NSCLC after Osimertinib failure May 2022 New Article: Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA NSCLC (IMpower010): A randomised, multicentre, open-label, phase 3 trial Welkom op de website van de Leuven Lung Cancer Group LLCG is een samenwerkingsverband tussen het Zorgprogramma Respiratoire Oncologie van het UZ Leuven en verwijzende artsen. Ik ben patient |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx Date: Sun, 23 Jan 2022 08:20:11 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Location: https://longkankerpatient.be/ HTTP/1.1 301 Moved Permanently Server: nginx Date: Sun, 23 Jan 2022 08:20:11 GMT Content-Type: text/html; charset=iso-8859-1 Connection: keep-alive Location: http://www.longkankerpatient.be/ HTTP/1.1 301 Moved Permanently Server: nginx Date: Sun, 23 Jan 2022 08:20:11 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Location: https://www.longkankerpatient.be/ HTTP/1.1 200 OK Server: nginx Date: Sun, 23 Jan 2022 08:20:12 GMT Content-Type: text/html; charset=UTF-8 Connection: keep-alive Cache-Control: no-cache Set-Cookie: laravel_session=eyJpdiI6IkRrU2tHMDlKZVBKeFN2VUpQXC9XVHB3PT0iLCJ2YWx1ZSI6IkxHejIyQUVHRjdJRzlPNlRlWHhPRGhUUlJOZG16Qk91bURRWHl2SFliUTFkVkE4RnRKOGFTM2ZUSUw5dE45NndsaElZQks4bE5lS3RGeDhtWXJxZmxnPT0iLCJtYWMiOiI2YmQwZmUxZjZmYjMyOTcyZTA2M2IyNjY5MzZmM2EyZDAwOGNmNGUxZjlmMWY5NjUwY2QzZWE4YmQzYTQxYjIyIn0%3D; expires=Sun, 23-Jan-2022 10:20:12 GMT; Max-Age=7200; path=/; httponly Cache-Control: max-age=2592000 Expires: Tue, 22 Feb 2022 08:20:11 GMT Accept-Ranges: none Access-Control-Allow-Origin: * Access-Control-Allow-Headers: origin, x-requested-with, content-type Access-Control-Allow-Methods: PUT, GET, POST, DELETE, OPTIONS Access-Control-Allow-Origin: * Access-Control-Allow-Headers: origin, x-requested-with, content-type Access-Control-Allow-Methods: PUT, GET, POST, DELETE, OPTIONS |
longkankerpatient.be Whois Information
Domain: longkankerpatient.be Status: NOT AVAILABLE Registered: Thu Nov 8 2007 Not shown, please visit www.dnsbelgium.be for webbased whois. Organisation: Combell nv Language: nl Phone: +32.92187979 Name: Combell nv Website: http://www.combell.com ns4.european-server.com ns3.european-server.com Please visit www.dnsbelgium.be for more info. |